Scrianen Beijing Daxing Bio-pharmaceutical Industry Base

Based on the long-term development strategy of the enterprise, in order to further improve the production scale, product quality level and research and development strength of the company, Beijing Scrianen Pharmaceutical  Co.,ltd has established a national independent innovation Demonstration zone in Zhongguancun. Beijing Daxing Bio-pharmaceutical Industry Base invested in the construction of a production research and development base, the production research and development base project covers an area of 38 acres, with a total investment of more than 300 million yuan, has been completed and put into operation at the end of 2015. Among them, the production center successfully passed the GMP certification and ISO quality, environment, occupational health system certification; The R&D center has R&D laboratories for chemical pharmaceutical preparations, chemical raw materials, Chinese medicine, health products, food, daily chemicals, etc., with nearly 100 R&D personnel, 50% of whom have master's and doctor's degrees, and has the ability to undertake large-scale national scientific research projects, especially in the field of folic acid research in the domestic leading position.